Arnatar Therapeutics
We are a biotechnology company pioneering RNA-based therapeutics to address high unmet medical needs in cardiovascular, metabolic, liver, and kidney diseases.
$50M Series A ·
Source: fundraisingfox.com
Total raised: $102M across 2 sourced rounds
All 2 rounds ↓Signals
Arnatar Therapeutics | 62 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $50M | — | fundraisingfox.com | |
| Series A | $52M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
- XLXuehai Liang Co-founder & Chief Executive Officersource: arnatar.com
- YWYanfeng Wang Co-founder & Chief Operating Officersource: arnatar.com
Investors
33E Bioventures
EEight Roads Ventures
FF-Prime Capital
GGaorong Capital
HHongsheng Capital
HHuajin Capital
JJifeng CapitalNNew Alliance Capital
TTransfar Capital
YYijing Capital
Companies like Arnatar Therapeutics
RResolution TherapeuticsSeries B+ · Oct 2024
KK2 Therapeutics$50M Seed · Aug 2026
RResalis Therapeutics$10.92M Series A · Jan 2024NNephronomicsSeed · Apr 2026
LLoxagen
VVico Therapeutics$71M Series B+ · Jun 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arnatar-therapeutics (get a free API key).